Switzerland-based Carbogen Amcis, a pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, has appointed Dr. Mojmir Vavrecka as chief operating officer. In his new role, Dr. Vavrecka will oversee manufacturing activities and technology development. He will report directly to Nick Green, president of the global contract research and manufacturing services (CRAMS) for Dishman Pharmaceuticals and Chemicals, Carbogen Amcis' parent company.

Dr. Vavrecka has more than 18 years of experience in the pharmaceutical sector and has a strong academic background in synthetic organic chemistry. Previously, Dr. Vavrecka served as site director for SAFC Phama, UK, overseeing manufacturing, project management, process development and quality control. Prior to this appointment, he served as head of chemical production for Fluka, Switzerland and worked for Hoffmann La Roche as plant and validation manager. He also holds a Ph.D. in chemistry from the University of Zürich.

The addition of Dr. Vavrecka follows Carbogen Amcis' November expansion of late phase service offerings and high-potency manufacturing at its Swiss sites.